- £87.02m
- £70.21m
- £57.96m
- 95
- 54
- 19
- 57
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 56.4 | 55.6 | 56.2 | 57.6 | 58 |
Cost of Revenue | |||||
Gross Profit | 30.9 | 30 | 31.3 | 30.9 | 32.1 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 51.1 | 48.7 | 46.4 | 50.3 | 50.2 |
Operating Profit | 5.39 | 6.96 | 9.85 | 7.3 | 7.75 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 5.24 | 6.74 | 9.56 | 7.17 | 8.09 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3.1 | 4.68 | 7.45 | 5.12 | 5.12 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 9.78 | 4.31 | 7.03 | 4.85 | 5.04 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 9.78 | 4.31 | 7.03 | 4.85 | 5.04 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.365 | 0.523 | 0.72 | 0.733 | 0.624 |
Dividends per Share |